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Congenital stationary night blindness type 2Defective retinal synaptic transmission in patients affected with congenital stationary night blindness type 2
(CSNB2) can result fromdifferent dysfunction phenotypes in Cav1.4 L-type calcium channels. Herewe investigat-
ed two prototypical Cav1.4 variants from either end of the functional spectrum. Using whole-cell and single-
channel patch-clamp techniques, we provide analysis of the biophysical characteristics of the point mutation
L860P and the C-terminal truncating mutation R1827X. L860P showed a typical loss-of-function phenotype at-
tributed to a reducednumber of functional channels expressed at theplasmamembrane as impliedby gating cur-
rent and non-stationary noise analyses. This phenotype can be rationalized, because the inserted proline is
predicted to break an amphipatic helix close to the transmembrane segment IIIS1 and thus to reduce channel sta-
bility and promote misfolding. In fact, L860P was subject to an increased turnover. In contrast, R1827X displayed
an apparent gain-of-function phenotype, i.e., due to a hyperpolarizing shift of the IV-curve and increased single-
channel activity. However, truncation also resulted in the loss of functional C-terminal modulation and thus
unmasked calcium-dependent inactivation. Thus R1827X failed to support continuous calcium inﬂux. Current in-
activation curtails the dynamic range of photoreceptors (e.g., when adapting to variation in illumination). Taken
together, the analysis of two representativemutations that occur in CSNB2 patients revealed fundamental differ-
ences in the underlying defect. These may explain subtle variations in the clinical manifestation and must be
taken into account, if channel function is to be restored by pharmacochaperones or related approaches.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Several channel dysfunctions have been described that are caused by
mutations in L-type calcium channel (LTCC)α1 subunits [1]. Mutations
in the CACNA1F gene, which encodes Cav1.4 LTCC α1 subunits, have
been associated with several X-linked visual disorders including
Åland Island Eye Disease (AIED) [2], cone-rod dystrophy (CORDX3)
[3], X-linked retinal disorder (XRD) [4], night blindness-associated
transient tonic down-gaze (NATTD) [5] and incomplete congenital
stationary night blindness (iCSNB, CSNB2) [6,7]. Amajority ofmutations
identiﬁed was amongst patients that were originally diagnosed with
CSNB2. Typical symptoms in CSNB2 are moderately low visual acuity,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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more of these symptoms may be absent [6]. In addition, some patients
report progressive photophobia. CSNB2 is therefore diagnosed on the
basis of abnormalities in the human electroretinogram (ERG), which
are compatible with a defect in neurotransmissionwithin the retina be-
tween photoreceptors and second-order neurons. The typical Schubert–
Bornschein ERG pattern of CSNB2 is onewith an overall electronegative
aspect, whichwas later further speciﬁed as theMiyake incomplete type
[8,9].
Cav1.4 channels are predominantly expressed at release sites of
mammalian photoreceptors in the outer plexiform layer of the retina.
Cav1.4 dysfunction is therefore expected to change neurotransmitter
release capacity and impair signalling to second-order retinal neurons.
Many single point mutations have been functionally characterized. In
the majority of the investigated mutants, channel activity was either
abolished or dramatically reduced. It is not known whether the pheno-
type results froma decrease in protein expression, from reduced protein
stability or from changes in the channel gating properties. Many Cav1.4
mutations are predicted to cause major structural changes, e.g. by trun-
cation of the long C-terminus. Truncation of the C-terminus, however,
does not necessarily result in misfolding of the channel. In fact, in
many instances, truncated channels can still form functional channels.
Cav1.4 channels lack calcium-dependent inactivation due to active
suppression by an inhibitory domain in their C-terminus [10,11].
This phenomenon is referred to as C-terminal modulation (CTM). It re-
lies on the interaction between a distal and a proximal C-terminal mod-
ulatory domain [10]. In Cav1.4 (but also Cav1.3 and Cav1.2 [12,13])
channels, CTM determines not only CDI but also activation gating prop-
erties. Cav1.4 mutations with impaired CTM are of particular interest
because (i) they display a gain-of-function due to a hyperpolarizing
shift of the Cav1.4-mediated window current. (ii) In addition, these
mutations reduce Ca2+ inﬂux due to occurrence of CDI [11,12]. (iii) By
analogy with recently published data on short Cav1.3 channels [12],
enhanced open probability is predicted in truncated Cav1.4 channels.
It is not clear, which of these processes dominates the phenotype of
Cav1.4 mutants with impaired CTM function.
The ultimate goal is to remedy the deﬁcits caused by the various
mutations linked to CSNB2. This is contingent on mechanistic insights
into the aberrations caused by the individual mutations. Here, we
selected two mutations from either end of the spectrum: we report
that the dysfunctional phenotype of point mutation L860P [14,15]
was accounted for by a change in protein stability, which resulted
in a drop in expression of functional channels. In contrast, in the C-
terminal truncation mutant R1827X [15], C-terminal modulation was
disrupted; this removed the break on calcium-dependent inactivation
and thus resulted in transient calcium inﬂux. In the absence of sustained
Cav1.4-dependent calcium currents, photoreceptors are, however, pre-
dicted to be limited in their adaptation to different levels of
illumination.
1.1. Experimental procedures
1.1.1. Cloning of mutant Cav1.4 channels
Both the CSNB2-associated point mutation Cav1.4 L860P [14,15] re-
ferred to as p.L849P in these publications and the truncation mutation
Cav1.4 R1827X ([15]; referred to as p.R1816X therein) were introduced
into the Cav1.4 α1 cDNA previously cloned from human retina
(Genbank accession number, JF701915, length of open reading frame
5898 base pairs). Numbering of amino acids is according to the canoni-
cal reference sequence UNIPROT entry number: O60840-1. Numbering
of thenucleotides (nt) in the constructs is given in parentheses.Mutants
were constructed by applying standard geneSOEing technique. The
mutation L860P was cloned in a two-step procedure, by replacing
AgeI/ClaI (2069-3993) cassette obtained by SOE-PCR in an AgeI/
ClaI (2069-3933)-cut Cav1.4 α1 construct in pBS. The mutated
AgeI/EcoRI (2069-5027) cassette from L860P pBS was ligated intoAge//EcoRI (2486-5444)-cut Cav1.4 α1 pCIneo construct. The muta-
tion R1827X was constructed by inserting a stop codon at position nt
6542 by SOE-PCR. An EcoRI/NotI (5444-7225) cassette containing
R1827X was ligated into the EcoRI/NotI (5444-7225)-cut Cav1.4 α1
pCIneo construct. A silent mutation for SmaI was introduced at nt po-
sition 6523 for identiﬁcation. Regions subjected to PCR were con-
ﬁrmed by sequencing (MWG) in all expression constructs. Cloning
of construct wild type Cav1.4 α1 in pCIneo has been described [16].
1.1.2. Cell culture and transfection
For whole-cell patch-clamp recordings, tsA-201 cells (ECACC,
#96121229) were cultured in Dulbecco's modiﬁed Eagle's medium
(DMEM, PAA, R15-801) supplemented with 10% fetal bovine serum
(Gibco, 10270-106), 2 mM glutamine (Gibco, 25030-032) and main-
tained at 37 °C/10% CO2. Cells were grown and split at 80% conﬂuency
using PBS-EDTA or trypsin for cell dissociation. Passage number did
not exceed 30 passages. For whole-cell patch-clamp recordings
tsA-201 cells were transiently transfected using ExGen500-invitro
(Fermentas, R0511) according to the manufacturer's protocol or via
calcium phosphate (CaPO4) precipitation. For a 25 cm2 ﬂask with
30–40% conﬂuency, 0.5 μg/2.25 μg (ExGen500-invitro/CaPO4) of
cDNA encoding the α1-subunits of either wt Cav1.4, R1827X or L860P
were mixed with 0.5 μg/1.25 μg auxiliary Cavβ3 and 0.5 μg/1.75 μg
Cavα2δ1-subunits. Cav1.342 α1-subunit cDNA was used as control for
gating current analyses (Genbank accession number: EU363339). A
plasmid encoding EGFP (0.025–0.25 μg)was added to visualize success-
fully transfected cells. In some experiments, a plasmid (0.1 μg) was co-
transfected that coded for the last 122 amino acids of Cav1.4 (C122).
Non-coding vector was added to keep the total DNA constant
(4.5–7.5 μg). After overnight incubation with the transfection mixture
cells were detached, replated on 35 mm cell culture dishes coated with
poly-D-lysine and were kept at 30 °C/5% CO2 prior to electrophysiolog-
ical measurements (24–48 h). For single-channel recordings, HEK-293
cells were cultured in Petri dishes in Dulbecco'smodiﬁed Eaglemedium
(DMEM, P010-11 0978, PAA, Austria) supplemented with 10% FBS
(A15-151, Sigma, Deisenhofen, Germany), penicillin (10 units/ml),
and streptomycin (10 μg/ml) (Sigma Aldrich). Cells were routinely pas-
saged twice a week and incubated at 37 °C/6% CO2. Cells were seeded
onto 60 mm polystyrene Petri dishes (Falcon, Heidelberg,
Germany) at a density of 1–2 × 104 cells/cm2. The amount of wild
type or R1827X α1-subunit, Cavβ3 and Cavα1δ-1, GFP and pUC cDNA
transfected was 0.5 μg, 0.5 μg, 0.5 μg and 0.5 μg and 3 μg, respectively.
The cDNA mixture was delivered to the cells by Effectene®
transfection (301425, Qiagen GmbH, Hilden, Germany) according to
the manufacturer's guidelines. Sixteen to 20 h after transfection, cells
were split and cultured in 35 mm polystyrene Petri dishes.
1.1.3. Immunoblotting
CaPO4-transfection was employed to wild type and mutant Cav1.4
channels in tsA-201 cells as described above; for comparison mock
transfections were done (α1 omitted; only β3, α2δ-1 and pUC). Mem-
branes from transfected cells were prepared after homogenization in
ice-cold lysis buffer: 10 mM Tris–HCl (pH 7.4) and protease mix:
0.2mMPMSF, 0.5mMbenzamidine, 1Mpepstatin, 2mMiodacetamide,
1 mg/ml leupeptin, 1 mg/ml aprotinin, and 100 mg/ml trypsin inhibi-
tor. Immunoblotting was carried out as previously described [17].
Membranes (30 μg protein)were loaded onto an 8% SDS gel. Expression
of recombinant subunits was monitored by blotting with α1 subunit-
selective polyclonal sequence-directed antibodies (anti-calcium chan-
nel α1 subunit, pan antibody, C1103, Sigma Aldrich). Speciﬁc band
sizes were observed at the expected molecular mass (in [kD]: wt,
L860P: 220; R1827X: 203). For cycloheximide (CHX) chase experiments
tsA-201 cells (conﬂuency 70–80%, 175 cm2 dish) were transfected with
plasmids (3.5 μg each) encoding of α1 (wild type or L860P) in a 1:1:1
ration with Cavβ3 and Cavα2δ1-subunits using Turbofect (Thermo
Scientiﬁc, R0531). In preliminary experiments the optimum conditions
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30 μM) for different periods (2, 4, 8 and 16 h). Finally cells were treated
42–44 h after transfection with 10 μMCHX for 2 and 4 h. Aliquots of the
membranes (containing 30 μg protein) were loaded onto a 6% SDS gel
(thickness: 1.5 mm). Immunoreactivity against Ponceau S staining
served as loading control. We used Ponceau staining rather than any
other housekeeping proteins, since the latter potentially also are de-
graded ([18]; also our observation). We therefore normalized the AUC
of the intensity proﬁle (ImageJ) of the immunoblot signal to the total
protein signal (difference in protein load was b10%) revealed by
Ponceau S staining.
1.1.4. Electrophysiological recordings
Forwhole-cell patch-clamp recordings, electrodes with a resistance of
2–5 MΩ were pulled from glass capillaries (borosilicate glass; 1.5 mm
diameter, 0.32 mm wall thickness; Science Products) using a micropi-
pette puller (P97, Sutter Instruments, USA) and ﬁre-polished with
an MF-830 microforge (Narishige, Japan). Cells were recorded in the
whole-cell conﬁguration using Axopatch 700B ampliﬁer (Molecular De-
vices, USA). Data were analyzed using pClamp 10 software (Molecular
Devices, USA). The pipette internal solution contained [in mM]:
135 CsCl, 10 HEPES, 10 EGTA, 1 MgCl2 adjusted to pH 7.4 with
CsOH (311 mOsm); bath solution [in mM]: 2–15 CaCl2, (BaCl2) 10
HEPES, 150 Choline-Cl, and 1 MgCl2, adjusted to pH 7.4 with CsOH
(320 mOsm). Current-voltage (I–V) relationships were obtained by
holding cells at a potential of−98 mV (holding potential, HP) before
applying 300-ms pulses to various test potentials. I–V curves were
ﬁtted to the equation I= Gmax (V− Vrev)/{1+ exp [(V0.5,act− V)/k]},Fig. 1. Location and expression of Cav1.4mutants L860P andR1827X. (a)Mutation L860P is locat
position is shown in a transmembranemodel of the Cav1.4 channel. Within the C-terminus, reg
been depicted: the putative EF handmotif (‘EF’), the IQ calmodulin bindingmotif (IQ) and the in
PCRD, proximal regulatory domain and C122, the last 122 amino acid residues of the C-terminus.
modelﬁgure. (b) Sequence alignment of amphipatic helix and helix S1of theCav1.x channels tog
sequence. The prediction indicated that in Cav1.4 the amphipatic helix begins at position Pro85
and the Cav1.x ion channels The S1 helix is indicated by a red bar, the position of the Leu860 in
amphipatic helix close to the voltage sensor of the wild type (upper ﬁgure) and the L860P mut
phobic residues (white) are facing the membrane, whilst the polar (green) and charged (blue
Expression of wild type (wt) and mutant Cav1.4 α1 subunits in tsA-201 cells (+β3 + α2δ-1
arrow marks the speciﬁc bands; theoretical molecular mass: 219 kDa for wild type and L860P,where Vrev is the extrapolated reversal potential, V is the test potential,
I is the peak current amplitude, Gmax is the maximum slope conduc-
tance, V0.5,act is the half maximal activation voltage and k is the slope
factor. The voltage-dependence of inactivation was assessed by apply-
ing a 50ms test pulse to Vmax before and after holding cells for 5 s at var-
ious conditioning test potentials. The (quasi) steady-state inactivation
curves were analyzed using the following Boltzman relationship I =
ISS + (1− ISS)/(1 + exp (V− V0.5,inact/kinact)), where I is the peak cur-
rent amplitude, Iss is the non-inactivating fraction, V is the membrane
potential, V0.5,inact is the half-inactivation potential, and kinact is the
slope factor. (±)-BayK8644 (Sigma Aldrich, B112, racemic) was dis-
solved in the external recording solution from a 10 mM stock solution
in dimethyl sulfoxide (ﬁnal concentration 0.1%) and perfused through
amicrocapillary onto cells using a pressure-driven (20–30 mmHg) per-
fusion system. Experiments showing currents bigger than 3 nA were
prospectively excluded from analysis of activation and inactivation pa-
rameters to guarantee high-quality voltage-clamp. Ca2+-dependent
inactivation (CDI) was quantiﬁed as the current remaining at the end
of 250ms depolarisations to different test potentials (expressed as frac-
tion of the peak current amplitude, r250). Parameter fwas deﬁned as the
maximal difference between r250 values of barium (IBa) and calcium
(ICa) inward current observed within the investigated voltage range.
ON-gating currents were digitized at 50 kHz and ﬁltered at 4 kHz and
quantiﬁed by current integration over the ﬁrst 2.4–2.6 ms of the test
pulse. The voltage dependence of Cav1.4 ON gating currents was deter-
mined by replacing the charge carrierwith 15mMMg2+ supplemented
with 15 μM GdCl3 to maximally eliminate inward and outward current
components. Cells were clamped to a holding potential of−98 mV anded in the II–III loopswhereas R1827X is a C-terminal truncationmutant. Their approximate
ulatory domains important for (voltage- and calcium-dependent) gating modulation have
teracting domains for the C-terminal modulation (CTM): DCRD, distal regulatory domain;
The length of the C-terminus comprising ~27% of the total protein is underestimated in this
etherwith the sequence of theNavAB template and the secondaryprediction of theCav1.4
9 and continues until residue His869. This helix is conserved between the NavAB template
domain III (D3_Cav1.4) by the black arrow. (c) Homologymodel of Cav1.4: a zoom to the
ant (lower ﬁgure) is depicted. Residue 860 is shown in yellow space ﬁlling mode. Hydro-
, positive/red, negative) residues are oriented towards the water phase of the cytosol. (d)
) was conﬁrmed in Western Blot experiments (one out of 7 experiments is shown). The
and 203 for R1827X. Mock, mock-transfected cells (β3 and α2δ-1 only).
Fig. 2. Representative currents and current–voltage relationships of wild type and
L860P channels. (a) Representative currents mediated by wild type (wt; upper panel,
cells: 11511001.abf, 11421023.abf) and L860P (lower panel, cells: 11325001.abf,
11331007.abf; tsA-201 cells;+β3 and α2δ-1 subunits). 15 mM Ca2+ or Ba2+ was used
as charge carrier. Cells were clamped to a holding potential of−98 mV and depolarized
for 300 ms (wild type) or 50 ms (L860P) to potentials ranging from −78 mV to +52
mV (10 mV increments) every 5 s. (b) Current densities for wild type (black) and L860P
(open circle) channels are depicted at different voltages for the charge carrier indicated.
Asterisks, recordings form mock transfected cells. Data are shown as means ± SEM.
Number of experiments is given in parentheses. For details and statistics see Table 1.
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increments for 10 ms. Capacitative transient currents were difﬁcult
to eliminate but they always showed a linear voltage‐dependence
(compared to the characteristic sigmoidal voltage-dependence of
gating currents). We estimated the number of channels expressed in
tsA-201 cell membranes by non-stationary noise analysis using the
following protocol: cells were depolarized from a holding potential of
−78 to +42 mV for 10 ms to maximally activate the channels before
stepping back to −48 mV for 10 ms. The mean current and variance
of 250–500 traces were calculated. To avoid interference with the
capacitative transient we started the analysis shortly after the peak
tail current reached its maximum (delay time: 5 × time constant of
the voltage-clamp). To calculate the number of channels as well as
the single channel current the following parabolic equation was used
σ2= i·I− (I2/N) + b, where σ2 is the variance of themean tail current,
i is the single channel current, I is themean tail current,N is the number
of channels and b is the background noise delineated by the variance
offset [19]. The mean single channel current i is indicated by the initial
slope of the curve and the interception point with the X-axis (I) repre-
sented the single channel currentmultiplied by the number of channels
expressed (N) [I= i×N] [19]. The number of channels per cell was nor-
malized to the cell size assuming a speciﬁc capacitance of 1 μF/cm2. All
experiments shown were corrected for liquid junction potentials of
−8mV. A number of cells had to be excluded from the analysis because
the data rather resembled a straight line than a parabola (whichwas the
case when the maximum open probability was far below 0.5). The por-
tion of excluded cells was higher in cells expressing L860P (33%) than
wild type (25.7%).In single-channel patch-clamp recordings Cav1.4
single-channel currents in GFP-positive cells were recorded 48–72 h
after transfection at room temperature (19–23 °C) as reported [12]. In
brief, HEK-293 cells kept in 35 mm culture dishes were washed and
placed in depolarizing bath solution containing [in mM]: 120 K-
glutamate, 25 KCl, 2 MgCl2, 10 HEPES, 2 EGTA, 1 CaCl2, 1 Na2-ATP, 10
dextrose (pH 7.4 with KOH). Patch pipettes made from borosilicate
glass (1.7 mm diameter and 0.283 mm wall thickness, Hilgenberg
GmbH,Malsfeld, Germany)were pulled using a Narishige PP-83 vertical
puller and ﬁre-polished using a Narishige MF-83 microforge (Narishige
Scientiﬁc Instrument Lab, Tokyo, Japan). Pipettes showed typical resis-
tances between 6 and 10 MΩ when ﬁlled with pipette solution
[in mM]: 110 BaCl2, 10 HEPES; pH 7.4 adjusted with TEA-OH. To en-
hance LTCC activity (S)-(−)-BayK 8644 (Tocris, 1546/10) was added
to the pipette solution at a concentration of 10 μM. Single
Ca2+channels were recorded in the cell-attached conﬁguration at test
potentials ranging from−30 to 10 mV and depolarizing test pulses of
150 ms duration at 1.67 Hz (HP of−100 mV). Single-channel currents
were ﬁltered at 2 kHz, −3 dB, 4-pole Bessel, and sampled at 10 kHz
with the Axopatch 1D ampliﬁer using pClamp5.5 software (Molecular
Devices, USA). The number of channels in a patch was estimated by
the stacked openings observed. The channel events were detected
using pClamp 6.0 software (Molecular Devices, USA), and Origin Pro 8
software (Microcal Software, Northampton, MA, USA) was employed
for graphic analysis. Single-channel gating analysis was performed as
described [21]. Note that data were not further ﬁltered for analysis.
Due to low activity at negative potentials unitary conductance of
Cav1.4 channels was determined based upon amplitudes taken from
well-resolved single-channel openings. Single-channel conductance
was calculated as slope of the unitary current–voltage relationship.
1.1.5. Sequence alignments and homology modelling
Sequence alignment was done as previously described [20] using
MUSCLE [21] and manually adjusted. Homology models were built
using the NaVAB crystal structure (PDB ID: 3RVY) [22] because the
NavAB sodium channel is the most closely related ion channel for
which a crystal structure has been determined. The NavAB sodium
channel can serve as a template for L860P mutant, because Leu860 is
still close enough to the S1 helix of the voltage sensor. For modelbuilding we applied MODELLER [23,24]. The best of 50 models, evaluat-
ed using the DOPE score [25] were selected for structural analysis.
1.1.6. Statistics
All values are presented as means ± S.E.M. for the indicated number
of experiments (n). For multiple comparisons statistical signiﬁcance was
determined by Kruskal–Wallis test followed by Dunnett's post-hoc test.
For comparisons of two groups, data were analyzed by Mann–Whitney
U-test or by Wilcoxon signed-rank test as indicated for individual
experiments. Statistical signiﬁcance was set at P b 0.05.
2. Results
2.1. Characteristics and expression of two selected Cav1.4 mutants
A stop mutation in C-terminus at position Arg1827 (also
p.Arg1816stop in [15]; Fig. 1a) was found in an 8-year old male patient
from a Belgian family who presented with a classic CSNB2 phenotype.
Full-ﬁeld ﬂash electroretinography (Suppl. Fig. 1) showed a pattern
consistent with a Schubert–Bornschein, Miyake incomplete type of
ERG [8,9]. The boy did not have any history of night blindness, but he
suffered from photophobia from birth until he was 6 years old, without
complaints of photophobia after that (for details see Supplemental
Table 1
Biophysical parameters and statistical comparison ofwild type, R1827X and L860P channels using different charge carriers. Data are presented asmeans ± SEM. CD, current density; Vrev,
reversal potential; V0.5, act, half maximal voltage of activation, kact, steepness of activation curve; Gmax, maximum slope conductance; V0.5,inact, half maximal voltage of inactivation, kinact,
steepness of inactivation curve; Maxinact, maximal inactivation observed at depolarized potential given in percent; ND, not determined. Statistics: we used the Kruskal Wallis test with
Dunn's post hoc test for multiple comparisons.
Wild type R1827X R1827X + C122 L860P
SEM N SEM N p vs. wt SEM N p vs. wt SEM N p vs. wt
15 mM Ca2+
CD [pA/pF] 13.93 0.99 92 14.04 1.74 40 N0.05 10.91 1.56 18 N0.05 4.34 1.90 13 b0.001
Vrev [mV] 63.46 0.72 92 65.42 0.84 40 N0.05 66.61 2.34 18 N0.05 79.65 5.74 13 b0.01
V0.5,act [mV] 0.96 0.45 92 −12.78 0.42 40 b0.001 3.07 1.83 18 N .05 3.63 1.25 13 N0.05
kact [mV] 9.60 0.12 92 8.50 0.14 40 b0.001 9.95 0.42 18 N0.05 12.61 1.11 13 b0.05
Gmax [nS] 0.37 0.03 92 0.27 0.03 40 b0.05 0.30 0.05 18 N0.05 0.08 0.02 13 b0.001
V0.5,inact [mV] −17.81 2.27 29 −29.56 1.09 30 b0.001 −18.83 6.58 5 N0.05 −12.83 1.61 4 N0.05
kinact [mV] −14.39 1.28 29 −8.35 0.49 30 b0.001 −8.25 1.43 5 N0.05 −13.79 2.06 4 N0.05
Maxinact [%] 91.71 1.98 29 82.87 2.04 30 b0.01 80.31 7.37 5 N0.05 88.84 5.40 4 N0.05
15 mM Ba2+
CD [pA/pF] 22.01 2.20 64 25.35 3.84 28 N0.05 6.95 0.58 10 b0.01 4.21 0.64 12 b0.001
Vrev [mV] 46.64 1.22 64 44.18 2.15 28 N0.05 51.34 3.84 10 N0.05 67.20 6.54 12 b0.001
V0.5,act [mV] −9.46 0.58 64 −24.55 0.73 28 b0.001 −3.57 1.89 10 N0.05 −11.05 1.50 12 N0.05
kact [mV] 8.7 0.11 64 6.14 0.23 28 b0.001 9.58 0.49 10 N0.05 9.04 0.74 12 N0.05
Gmax [nS] 0.65 0.07 64 0.54 0.09 28 N0.05 0.19 0.03 10 b0.01 0.09 0.02 12 b0.001
V0.5,inact [mV] −26.59 2.02 19 −29.46 2.57 13 N0.05 ND ND ND ND −33.46 2.41 4 N0.05
kinact [mV] −10.33 0.66 19 −12.31 1.99 13 N0.05 ND ND ND ND −11.55 2.58 4 N0.05
Maxinact [%] 84.94 2.94 19 76.12 3.47 13 N0.05 ND ND ND ND 98.09 1.10 4 b0.05
2 mM Ca2+
CD [pA/pF] 4.48 0.47 11 8.14 1.47 19 N0.05 4.30 0.53 9 N0.05 ND ND ND ND
Vrev [mV] 60.52 3.02 11 64.79 4.31 19 N0.05 62.04 4.72 9 N0.05 ND ND ND ND
V0.5,act [mV] −22.40 1.42 11 −29.41 1.84 19 N0.05 −10.79 3.69 9 N0.05 ND ND ND ND
kact [mV] 7.56 0.51 11 6.97 0.27 19 N0.05 9.66 0.64 9 N0.05 ND ND ND ND
Gmax [nS] 0.08 0.01 11 0.17 0.03 19 N0.05 0.18 0.07 9 N0.05 ND ND ND ND
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cause the proximal regulatory domain important for CTM of Cav1.4 is
still present in R1827X channels. This is in contrast to a previously pub-
lished truncation mutant [10] and provided us with the opportunity to
test, if complementation with the missing C-terminal fragment func-
tionally rescues the R1827X mutant (see below).
We selected a second mutation, where a proline residue replaced
Leu860 (p.Leu849Pro in [14,15]). The L860P mutation is located in the
loop between transmembrane domains II and III in a conserved
amphipatic helix (Fig. 1b), which runs in parallel to the membrane
plane and precedes the S1-helix of transmembrane domain III
(Fig. 1c). As shown in Fig. 1c, position 860 is on the membrane-facing
side of the amphipatic helix. As indicated in Fig. 1b, the helix begins at
position 859 with another proline, which is a frequent helix capping
residue. The subsequent second proline, however, shows strong helix
breaking properties because it lacks the amide hydrogen necessary for
helical hydrogen bond formation. In wild type Cav1.4, the hydrophobicFig. 3. Voltage-dependent activation and inactivation properties of wild type and L860P
channels using 15 mM Ca2+ as charge carrier. Calculated ﬁt parameters in [mV]: V0.5,act:
wild type (wt): 1.0 ± 0.5, L860P: 3.6 ± 1.3; kact: wild type: 9.6 ± 0.12, L860P: 12.6 ±
1.11*; V0.5,inact: wild type:−17.8 ± 2.3, L860P:−12.8 ± 1.6; kinact: wild type:−14.4 ±
1.3, L860P: −13.8 ± 2.1. *, p b 0.05; ***, p b 0.001. Colour code for wild type (a) and
L860P (b) is as in Fig. 2. The dotted lines indicate the 95% conﬁdence interval of the ﬁt.
Data are presented as means ± SEM for the indicated number of experiments.side chain of Leu860 is predicted to extend into the hydrophobic core of
the membrane (Fig. 1c). Moreover, the proline mutation changes the
long hydrophobic residues Leu into a compact hydrophobic residue
(Fig. 1d).
These two prototypical Cav1.4 mutants were heterologously
expressed in tsA-201 cells and the presence of the proteins conﬁrmed
by immunoblotting (Fig. 1e).2.2. Functional expression of mutant L860P channels
Themodel depicted in Fig. 1 predicts that the substitution of Leu860
by proline impairs the folding of the mutant ion channel. Impaired
folding of membrane protein results in its retention in the endoplasmicFig. 4. Gating current properties of wild type and L860P channels. (a) Representative
traces showing gating currents for Cav1.4 wild type (wt) and L860P channels. We never
detected a distinct gating current for L860P channels. Mock-transfected cells were used
as negative and Cav1.342-transfected as positive control. (b) Voltage-dependence of inte-
gratedON-gating currentswas recorded in the presence of 15mMMg2+ and 15 μMGd3+.
Parameters describing the QON–voltage relationship for wild type Cav1.4: V0.5:−4.0 ±
4.0 mV, k: 23.1 ± 1.8, n = 11.
Fig. 5. Potentiation of current amplitude of wild type and L860P channels by the LTCC activator BayK 8644. (a) BayK concentration-response relationship forwild type IBa potentiation. The
solid line indicates a nonlinear ﬁt to the data (logEC50 [M] =−6.49 ±−0.05; EC50 = 0.8 μM). The data point observed for the highest concentration was excluded for the ﬁt analysis
because we used a racemic mixture showing antagonistic properties at high concentrations. (b) Representative traces of maximal IBa for L860P ± BayK compared to mock + BayK;
3 μM(c, d) Effect of 3 μMBayKon the current density ofwild type (wt, c) or L860P channel expressing cells (d) at different voltages. BayKwas completelywashed out after each application
(grey up-triangle). Ctl,without BayK. (e) Effect of BayKon themaximal current density ofwild type and L860P. Friedman-testwithDunn's post hoc testwas used formultiple comparisons:
***, p b 0.001, ##, p b 0.01 versus respective control. (f) Fold-increase of peak current density in the presence of BayK for wild type (black) and L860P (grey) currents. (g) Extent of
potentiation of current density of wild type or L860P channels observed at various voltages. *, p b 0.05, **, p b 0.01, ***, p b 0.001; MannWhitney U-test.
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L860P. This was indeed observed: whole-cell patch-clamp recordings
showed a signiﬁcant reduction in current density for L860P compared
to wild type irrespective of whether Ca2+ (Fig. 2, left) or Ba2+ (Fig. 2,
right) was used as the charge carrier (see also Table 1). Recordable
L860P currents differed from those found in mock-transfected (β3/
α2δ-1) cells which mediated no detectable voltage-dependent inward
currents (Fig. 2). Small sized L860P currents (15 mM Ca2+: 4 versus
14 pA/pF inwild type t; Table 1) did not allow us to perform reliable ex-
periments at lower (i.e. more physiological) Ca2+ concentrations. How-
ever, both activation (Figs. 2, 3) and inactivation (Fig. 3) gatingFig. 6.Channel number estimation forwild type and L860P investigating non-stationarynoise an
(to maximally activate Cav1.4 channels) before stepping back to−48 mV for 10 ms (a potenti
current and variancewere calculated from 250 to 500 traces within the shaded area. (b, c) Exem
cells: 12n12019.abf, 12n28006.abf, 12n29018.abf, 12d01001.abf) or L860P (in c, cells: 12n14
parabolic data ﬁt. The initial slope gave the mean single channel current i, and the interception
of channels expressed (N) [I= i × N].properties were comparable to that of wild type currents (see also
Table 1).
Reduced current density can be attributed to a decline in the number
of channels expressed in the plasma membrane. Alternatively, it may
also arise from changes in the single channel properties. Immunoblots
were performed with membrane fractions prepared by differential
centrifugation. The endoplasmic reticulum represents the bulk of
these membranes, whilst the plasma membranes are only a minor
fraction of the total membranes. Hence, it is not possible to deduce the
level of surface expressed channels from the immunostaining intensity,
although therewas a trend consistentwith reduced expression of L860Palysis (a) Cellswere depolarized from aholding potential of−98mV to+42mV for 10ms
al at which Cav1.4 channel are still closed; 15 mM Ba2+, see Figs. 2b and 5c, d). Mean tail
plar variance versusmean current amplitude plots for cells expressing wild type (wt; in b;
039.abf, 12n23024.abf, 12n23030.abf, 12n27030.abf) channels. Solid lines represent the
point with the X-axis (I) represented the single channel current multiplied by the number
Fig. 7. Degradation of wild type and L860P channels. Transfected tsA-201 cells for CHX
chase experiments were processed as described in Experimental procedures. (a) Total
protein was prepared at time point 0 and after 2 and 4 h of exposure to CHX (10 μM).
One out of 5 experiments is depicted for both wild type (wt) and L860P. L860P protein
was degradedmore rapidly than wild type, a characteristic of destabilized, misfolded pro-
tein. (b) Immunoreactivity against Ponceau S staining served as loading control. We also
investigated an anti- β-tubulin antibody (shown above) (c) Protein stability normalized
to total protein signal revealed by Ponceau S staining. L860P protein was degraded more
rapidly than wild type, a characteristic of destabilized, misfolded protein. *, p b 0.05,
two-way Anova with Bonferroni post test. Data are presented asmeans± SEM for the in-
dicated number of experiments.
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dressed this question by approaches that relied on recording functional
channels: a reduction in the nonlinear gating charge movement (gating
currents, [26]) indicates a decrease in the number of channels capable of
undergoing voltage-dependent gating. Hence, it is a direct proof for a
lower number of Cav1.4 channels at the plasma membrane. We mea-
sured gating currents by replacing the Ca2+ or Ba2+ with an equimolar
concentration of Mg2+ in the bath solution supplemented with the
pore-blocking cation Gd3+ (15 μM) to entirely block inward currents
and minimize outward currents. Wild type Cav1.4 gating currents
were clearly visible (Fig. 4a, top trace; n = 11) and showed typical sig-
moidal voltage-dependent behaviour (Fig. 4b). In contrast, we never ob-
served distinct gating currents for L860P (n= 4) (Fig. 4a, second trace;
n= 4). Rather, recordings were comparable to those obtained inmock-
transfected β3/α2δ-1 cells (Fig. 4a, third trace, n = 6).
We further corroborate this ﬁnding by non-stationary noise analysis
(NSNA). This provided an estimate of the number of channels per
transfected tsA-201 cell. We conducted NSNA in the presence of 3 μM
of the LTCC activator BayK8644 to increase the mean open time and
thus allow for more sensitive data analysis (Fig. 5). This concentration
caused maximum activation of wild type Cav1.4 (Fig. 5a). BayK8644
also clearly augmented currents through Cav1.4 wild type and L860P
channels, but it did not have any detectable effect in mock-transfected
cells (Fig. 5b).
Tail currents reﬂect the sequential closure of individual channels;
the actual current is the sum of currents through individual channels
that are still open. To exclude potential differences in the intrinsic clos-
ing rate of the channels we calculated the kinetics of deactivationwhich
were not signiﬁcantly different between wild type and L860P (tail cur-
rent decay: τ [ms]: wild type: 0.17 ± 0.03, n = 8; L860P 0.15 ± 0.03,
n = 9; p N 0.05, Mann–Whitney U-test (in the presence of 15 mM
Ba2+ and 5 μM BayK). Fluctuations (non-stationary noise) are caused
by opening and closing of ion channels. Hence, there is no (or low)
noise, if all of the channels are permanently closed, because the proba-
bility of ﬁnding the channel open, Po is (close to) zero. The same is
true, if all channels are permanently open (Po = 1). Accordingly, the
variance of the current, (pA2, i.e., the sum of squared deviations from
themean)will be small (Fig. 6a). Fluctuations (variance)will be highest
when Po is around 0.5. The plot of the trial-to-trial variance against cur-
rent amplitude at different time points was best ﬁtted with a parabolic
function (Fig. 6 b, c).We concluded fromour experiments that the num-
ber of wild type and L860P channels was generally lowwith a tendency
to less expression of mutant L860P channels (channels/μm2 for wild
type: 2.5 ± 0.3, n = 27 and L860P: 1.9 ± 0.3, n = 14; p = 0.13, Mann
Whitney U-test).
Under our strong depolarizing conditions (+42 mV) used in NSNA
we could also estimate the maximal Powhich was similar in wild type
and L860P (wild type: 0.63 ± 0.02, n = 26; L860P: 0.61 ±0.03, n =
14; p = 0.4, Mann–Whitney U-test). These analyses do not rule out an
effect of the L860P mutation on single channel activity of Cav1.4 at
physiologically more relevant lower potentials.
2.3. Loss-of-function phenotype of mutant L860P channels
Considering the study by Doering and colleagues, activity of single
Cav1.4 channels is expected to be quite low [27]. Nevertheless, it was
possible to perform single channel analyses in wild type and mutant
Cav1.4 channels (see also Fig. 11). We increased the fraction of sweeps
with active channels by recording IBa (110 mM charge carrier) in the
presence of 10 μM BayK8644 in the pipette solution. At a potential of
−20 mV the number of active sweeps was slightly higher in L860P
than in wild type (factive [%]: wild type: 2.5 ± 0.4, n = 5; L860P:
9.8 ± 2.9, n = 5; p b 0.05) as was the Po (in [%]: wild type: 0.058 ±
0.009, n= 5; L860P: 0.14± 0.082, n= 5; p b 0.05). However, these ef-
fects were not seen at higher potentials (−10 and 0 mV) and do there-
fore not indicate a left shift in activation. These ﬁndings are in line withour whole-cell patch‐clamp experiments. We observed apparent open-
ings with the amplitude slightly above baseline noise that we did not
identify as Cav1.4 channel activity because such events were also
detected in untransfected cells (not shown). Although we did not
ﬁnd a signiﬁcant difference in the mean open time (in [ms] wild type:
0.39 ± 0.03, L860P: 0.4 ± 0.03) we cannot rule out that such apparent
openings interfered to a minor extent with our analyses.
We further determined the stability of L860P in a CHX chase exper-
iment. CHX blocks the translocation step in elongation and therefore in-
hibits protein synthesis [28]. The model outlined in Fig. 1c predicts that
L860P protein is less stable than thewild type because of destabilization
of the amphipatic helix by P860. This conjecture was veriﬁed by exam-
ining the fate of newly synthesized L860P protein after addition of CHX.
A representative immunoblot is shown in Fig. 7: the levels of wild type
Cav1.4 remained essentially constant over the ﬁrst 4 h-period after the
CHX block had been imposed. In contrast, L860P already started to de-
crease after 2 h. This was seen in 5 out of 5 experiments with L860P.
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periments, but in two experiments the decrease in protein level was sim-
ilar to L860P. While we do not understand the source of the variability in
the case ofwild type Cav1.4, theseﬁndings indicate that the proline inser-
tion leads to higher Cav1.4 protein turnover in transfected tsA-201 cells.
Taken together, the observations are consistent with amodel, where
the reduced functional activity of L860P channels arises from a reduc-
tion in protein stability (and therefore fewer channels in the mem-
brane) rather than any major additional change in channel gating.2.4. Functional expression of mutant R1827X channels
We monitored expression of R1827X channels by recording their
voltage- and time-dependent properties (15 mM or 2.5 Ca2+ and
15 mM Ba2+; Fig. 8a, Table 1). Under physiological Ca2+ concentrations
(2 mM), currents through wild type channels activated at negative po-
tentials (5% current activation at−29.2 ± 0.7 mV). R1827X channels
showed a shift in the voltage-dependence of activation to more negative
voltages (seen in all recording conditions Fig. 8b, Table 1), typical for
Cav1.4 channels lacking CTM [10]. The voltage-dependence of inactiva-
tion was also shifted to negative potentials in 15 mM Ca2+ resulting in
a negative shift of the window current (Fig. 8c, Table 1).
As expected, IBa inactivation was slow in wild type Cav1.4; this
voltage-dependent inactivation was even slower in R1827X during theFig. 8. Representative currents and gating properties of wild type and R1827X channels. (a
12206004.abf, 11407026.abf; tsA-201 cells:+β3 andα2δ-1 subunits). (b) Current densities for
indicated. Data are shown asmeans±SEM.Number of experiments is given inparentheses. For
using 15mMCa2+. Calculatedﬁt parameters in [mV]: V0.5,act:−12.8± 0.4***; kact: 8.5± 0.14; V
for wild type taken from Fig. 3 as a comparison. Data are presented as means ± SEM for the in5 s depolarizing pulses (Fig. 9a, b). We compared themaximal inactiva-
tion of IBa observedwith the (quasi) steady-state protocol (Fig. 8c) with
the corresponding IBa inactivation during a test pulse to the voltage of
maximal current inﬂux (Vmax) (Fig. 9a, b): we noticed that these data
were not consistent. In the steady state protocol maximal inactiva-
tion was about 92 and 83%, whereas in the ‘Vmax’ protocol we ob-
served 76 ± 5.4% and 49.4 ± 5.3% inactivation for wild type (n =
12) and R1827X (n = 5), respectively. This difference can either be
attributed to run down during the long-lasting experiment [29] or
may result from a slow recovery from the inactivated state. As seen
in Fig. 9c and d, recovery from IBa inactivation was indeed very
slow (~120 s) and was twice as long as the inter-sweep interval in
our steady state protocol. We therefore assume that the observed
difference is accounted for by accumulation of the channel in the
inactivated state. A comparison of wild type and R1827X showed a
similar mono-exponential time course of recovery from inactivation
(Fig. 9d). Recovery was complete for R1827X (105.1 ± 6.0%). The
current amplitude measured for wild type Cav1.4 reached about
90% of the control current amplitude. Maximum recovery of wild
type Cav1.4 was estimated from the ﬁtted curves and was found to
be variable, but it did not differ signiﬁcantly from 100% (p N 0.05,
Wilcoxon signed-rank test, n = 9).
In the presence of calcium, currents through R1827X channels
decayed in a manner consistent with the absence of CTM: ICa through
Cav1.4 R1827X inactivated rapidly (cf. traces recorded in the presence) Representative currents mediated by mutant R1827X channels (cells: 11006042.abf,
wild type (wt) or R1827X channels are depicted at different voltages for the charge carrier
details see Table 1. (c) Voltage-dependent activation and inactivation properties of R1827X
0.5,inact:−29.6± 1.1***; kinact:−8.4±0.5. ***, p b 0.001. The dotted lines show thedataﬁt
dicated number of experiments.
Fig. 9. Inactivation and recovery properties of in wild type and R1827X channels. (a) Inactivation sample traces recorded from cells expressing either wild type (wt) or R1827X channels
during a 5 s inactivating test pulse to Vmax (cells: 11325001.abf; 11331007.abf for wild type and R1827X). (b) Extent of inactivation during the 5 s test pulse. Percent of inactivation was
76.1 ± 5.4, n = 12 and 49.4 ± 5.3*, n = 5 for wild type and R1827X, respectively; *, p b 0.05, Mann–Whitney U-test (c) Upper panel: protocol to elicit recovery from inactivation: cells
were depolarized to+2mV for 50ms (TP1; ctl, control) followed by an inactivating prepulse to+22mV for 5 s and allowed to recover at a holding potential of−98mV for the indicated
time before a second TPwas applied (+2mV, 50ms; TP2). Lower panel: representative experiment for wild type channel during TP1 and TP2 at different time points. (d) Recovery curves
for wild type or R1827X using 15mM Ba2+ as charge carrier. Currents elicited during TP2 were normalized to the TP1 current amplitude. Data were best ﬁtted with a mono-exponential
function (solid line) yielding time constants τ [in ms] 55.9± 11.1 and 45.9± 8.6 for wild type and R1827X, respectively (p N 0.05, Mann–WhitneyU-test). Total recovery was 87.5± 5.4
and 105.1 ± 6.04% for wild type and R1827X respectively. No signiﬁcant difference from 100% was observed; p N 0.05, Wilcoxon signed-rank test.
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calcium-dependent inactivation (cf. Fig. 10b, d).
Differences between R1827X and wild type Cav1.4 channels may
arise from changes in the gating mechanism. We previously showed
that short forms of Cav1.3 channels had a much higher Po than long
Cav1.3 channels [13]. It is evident that there is an analogy with
R1827X, which is a short version of wild type Cav1.4. Therefore we an-
alyzed single channel activity of R1827X channels using 110 mM Ba2+
as charge carrier. In the presence of 10 μMBayK8644, single-channel ac-
tivity of wild type Cav1.4 steeply increased from 0.6 ± 0.1% at−20mV
(n=5) to 5.0± 1.2% at+10mV (n=2). This indicates that the poten-
tials appliedwerewithin the range of the activation threshold. As can be
seen from representative traces depicted in Fig. 11a, the activity of sin-
gle channel activity of R1827X was signiﬁcantly higher than that of
wild type. This was not due to a change in the open times (Fig. 11c)
but to an increase in the open probability: at any given test potential
the Po of R1827X was higher that of wild type channels (Fig. 11d).
These data are consistent with the leftward shift of current-voltage
curve for R1827X observed in whole-cell recordings (cf. grey curves in
Fig. 8b). Based on the amplitudes of single openingswe calculated a uni-
tary conductance that was similar for wild type and R1827X channels
(8.9 ± 1.0 and 10.9 ± 0.5 pS, n = 4 and 5, respectively; p N 0.05;
Fig. 11e). The difference in the unitary conductance of wild type chan-
nels compared to data by Doering and colleagues (~4pS, [27]) is likely
explained by the different analytic approach and the use of additional
ﬁltering in their study.
2.5. Loss-of-function phenotype of mutant R1827X channels
It is difﬁcult to classify R1827X channels because they show an ap-
parent gain‐of function due to a hyperpolarizing shift of the window
current (Fig. 8c), which is likely due to the increase in Po (Fig, 11d).Concomitantly, they display a loss-of-function due to calcium-
dependent inactivation, which reduces Ca2+ inﬂux (Figs. 8a and
10b, d). The experiments presented so far did not address the ques-
tion, which of these changes in channel function were of pathophys-
iological relevance. When we calculated the charge transfer during
300 ms test pulses to various potentials (2 mM Ca2+, Fig. 10f), we
did not ﬁnd any signiﬁcant difference between wild type and
R1827X in the physiologically relevant voltage range (−55 to
−35 mV). However, we observed a frequency-dependent decrease
in the charge transfer when we applied 20 ms depolarizing pulses
to −20 mV (corresponding to −42.4 mV and −36.6 mV for wild
type and R1827X channels, respectively; 2 mM Ca2+) at frequencies
of 1, 2 and 5 Hz (Fig. 12a) from a holding potential of−70 mV. These
experiments were done in the presence of 3 μM BayK8644 and
15 mM Ca2+ as charge carriers because otherwise Cav1.4 currents
were too small at the given voltages. Ca2+ inﬂux through wild type
Cav1.4 remained constant irrespective of frequency (Fig. 12b, c). In
contrast, Ca2+ entry through R1827X channels was progressively
decreased at 2 and 5 Hz (Fig. 12b, d). This ﬁnding must result from
calcium-dependent inactivation. This interpretation was substanti-
ated by examining the gain-of-function mutation I745T ([30],
which shows a−30mV shift in the voltage dependence of activation
[29]; also our observation, not shown). Under the conditions
employed in Fig. 12, I745T was indistinguishable from wild type
(n = 4 − 6). This protocol was designed to mimic conditions of
light illumination (at the holding potential) with short periods of
darkness (during the test pulse); 5 Hz is a low frequency used to
assess the ﬂicker fusion frequency under conditions for scotopic rod vi-
sion [31]. We therefore conclude that, under physiological conditions,
truncation of the C-terminus of Cav1.4 results in a loss of function because
the truncated channels are incapable of supporting continuous calcium
inﬂux during changes in illumination. Usually this is preserved by the
Fig. 10. Calcium-dependent gating properties of R1827X channels and its functional rescue. (a, b) Comparison of the r250 values (ratio between peak current and current after 250-ms of
depolarization) at the indicated potential using either 15 mM Ba2+ (ﬁlled circles), 15 mM Ca2+ (open circles) or 2 mM Ca2+ (open squares) as charge carrier for (a) wild type (wt) and
(b) R1827X. (c) Comparisonof the r250 values in cells expressing R1827X togetherwith theGFP-tagged C-terminal fragment Cav1.4-C122 (C122; corresponding to the last 122 amino acids of
the Cav1.4 C-terminus). (d) Normalized representative currents for R1827X alone (+β3+ α2δ-1) (grey; cell: 12426012.abf) or together with C122 (black; cell: 11915028.abf). Cells were
depolarized to the potentials indicated. (e) Activation curves ofwild type (black circles), R1827X alone (grey circles) or R1827X+C122 (up-triangle). Data are presented asmeans± SEM.
Number of experiments is indicated in parentheses. For statistical comparison of parameters see Table 1. (f) Integrated currents corresponding to the area under normalized ICa (transfer
of charge Q) during 300ms pulses to various test potentials are shown for wild type and R1827X channels compared at different voltages using 2mMCa2+ as charge carrier. No difference
in the charge transfer between wild type and R1827Xwas observed in the voltage range physiologically relevant for photoreceptor function (−55 to−35 mV). Number of experiments
performed is given in parentheses.
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family of LTCCs likely to be explained the very slow entry of Cav1.4 chan-
nels to the closed-state inactivation Cav1.4 (Suppl. Fig. 2 and Suppl.
Table); in comparison to Cav1.2 [32].
2.6. Rescue of mutant R1827X channels
The experiments summarized above were designed to provide
mechanistic insights into the dysfunction underlying two repre-
sentative Cav1.4 channelopathies. The acid test for a mechanistic
insight is that it can be put to use to remedy the condition. The
proximal regulatory domain of the CTM is still present in
R1827X channels (Fig. 1a). Accordingly, we tested whether we
can functionally rescue the R1827X mutant by supplying the
missing (distal) portion of the CTM domain. This was indeed the
case: co-expression of a separate C-terminal peptide (C122) that
contains the distal C-terminal regulatory domain restored chan-
nel properties to mutant R1827X channels that rendered them
indistinguishable from wild type Cav1.4 channels: calcium-
dependent inactivation was abolished (Fig. 10c, d) and voltage-
dependent activation was also shifted to the range of the wild type
channel (Fig. 10e).3. Discussion
Clinical medicine deﬁnes disease phenotypes by extracting key
features from variable manifestations. These diagnostic categories are
useful for the management of patients and for deﬁning the standard of
care. It is, however, clear that some of the variations in disease manifes-
tations arise from different mutations in the individual gene and/or in
the genome of the individual (giving rise to modifying genes). CSBN2
is a case in point. The clinical course is variable and there are severalmu-
tations. Here, we selected the mutation L860P. This substitution of pro-
line for the non-conserved leucine at position 860 was also previously
identiﬁed independently in two families [14,15]. Based on molecular
modelling, L860P was suspected to result in destabilization of the pro-
tein. It is representative of additional mutants that are nested in the
core channel folding domains (for review see ref. [22]). We selected
an additional mutation R1827X that results in truncation of a functional
domain that is absent in closely related channels (e.g., short Cav1.3
channels; 12) and thus unlikely to impair protein folding. Our experi-
ments document that CSBN2 is the phenotypic manifestation of very
distinct mechanistic defects.
In L860P channels, our functional data point to a loss-of-function due
to a reduced number of functionally active channels expressed without
Fig. 11. Single-channel recordings obtained with eitherwild type or R1827X channels. (a) Exemplary consecutive traces (obtained with 110mMBa2+ as charge carrier in the presence of
10 μMBayK) showenhanced activity of R1827X channels compared towild type (wt) at different test potentials. (b–d) Statistics on single-channel gating parameters: (b) fraction of active
sweeps, (c) open times, (d) open probability (Po). Note that the Po of R1827X channels was higher at any given test potential. (e) Analysis of amplitudes obtained from well-resolved
single-channel openings at different test potentials revealed similar unitary conductance of 8.9 ± 1.0 pS, n = 5 and 10.9 ± 0.5 pS, n = 4 for wild type and R1827X, respectively.
*, p b 0.05; **, p b 0.01; ***, p b 0.001; unpaired Student's t-test.
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ed by both our whole-cell and single-channel experiments. Due to a
similar level of reduction of Cav1.4 activity it is tempting to askwhether
the Cacna1fnob2 mouse might mimic the functional consequences of the
L860P mutation for retinal transmission. ERG recordings from
Cacna1fnob2 mice showed a selective b-wave defect under scotopic and
photopic adaptation conditions. Retinal structures in these mice were
disorganized with a substantial reduction in the thickness of the outer
plexiform layer with extension of ectopic neurons to the outer nuclear
layer [33]. This mouse model was initially reported to carry a natural
Cav1.4 nullmutation before. Doering and colleagues then demonstrated
that approximately 10% of the mRNA represented a transcript in which
alternative splicing removed the mutation and therefore coded for a
fully functional Cav1.4 protein [32]. The present observations show
that heterologously expressed wild type channels were quite stable;
similar to observations were made in native tissue or (neuronal) cell
lines in other voltage-gated calcium [34–36] or also sodium channels
[37–39]. In case of the L860P mutation, homology modelling implied
an impact on the channel stability that might result in misfolded
Cav1.4 channel protein. In line with this hypothesis our CHX experi-
ments indicated that themutated channel is subject to increased degra-
dation. To the best of our knowledge this is the ﬁrst report showing this
experimentally for a Cav1.4 mutation causing CSNB2 in patients. We
have chosen the L860P mutant as one example of many CSNB2 muta-
tions that are suggested to result in a loss-of-function due to decreased
protein stability. Detailed morphological studies on a Cacan1f-deﬁcient
mousemodel showed that loss of Cav1.4 channels causes defects in rib-
bon synapse formation and aberrant cone morphology, displaying alsosigns of cone degeneration [40–43]. Although no CSNB2 mouse models
carrying potentially folding deﬁcient Cav1.4 mutations exist so far, it's
well accepted in many other inherited retinal diseases that mutations
in the associated proteins cause misfolding or defective targeting [44,
45]. As a general concept these processes put a burden on the protein
degradation machinery and might therefore also trigger cell death.
Cav1.4 truncatingmutationswith impaired CTM function previously
led to the discovery of a novel inhibitory feedback mechanism in LTCCs
that depends on a gating modiﬁer in the C-terminus [11–13,46]. This
opened a new ﬁeld of LTCC research that can use this intramolecular
modulator as study tool to adjust intracellular Ca2+ activity. Clinical
data from ﬁve patients from two families (one is reported in this
study) point also to a ‘hot spot’ for CSNB2 mutation in the C-terminus
of Cav1.4 channels. A hyperpolarizing shift in the current voltage rela-
tionship is suggested to result in a reduction of the dynamic range of
the photoreceptor.We can speculate about the consequences for retinal
function e.g. in the rod pathway: a reduction in the dynamic range of
transmission from darkness to light would mean less depolarization of
the rod bipolar cells at a given light intensity. AII amacrine cells might
be activated to a lesser degree and ON ganglion cell output is expected
to be decreased. AII amacrine cells also feed rod signals via inhibitory
glycinergic synapses into OFF cone bipolar cells and from there to OFF
ganglion cell, and therefore inhibit the OFF pathway. One might expect
that this inhibition is also suppressed in mutant retinas. The interpreta-
tion of the functional phenotype in R1827X channels is complicated by
the occurrence of prominent inactivation of calcium current at poten-
tials relevant for photoreceptor signalling. However, the expected re-
duced calcium inﬂux predicts a further reduction in the dynamic
Fig. 12. Frequency-dependent inactivation of wild type andmutant R1827X channels. The
experiment was performed in the presence of 15 mM Ca2+ and 3 μM BayK and using the
following pulse protocol (a): 20 ms depolarizing pulses to −20 mV were applied at
frequencies of 1, 2 and 5Hz from a holding potential of−70mV. (b) Representative traces
for wild type (wt; cell: 13122089.abf) and R1827X (cell: 13122049-55.abf) at different
frequencies are depicted in the lower panel. Black traces represent the ﬁrst, grey the
second pulse of the train. (c, d) Frequency-dependent changes in the charge transfer in
wild type (n = 3; c) and R1827X (n = 5, d) at 1, 2 and 5 Hz. All integrated currents
were normalized to the ﬁrst (Q0) 20 ms depolarizing pulse (Q/Q0).
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able that allows testing for these effects in isolatedwhole-mount retinas
and/or in vivo.
Importantly, analyses of in vivomodels have to take into account
that the altered Ca2+ signalling mediated by either loss-of-function
phenotype might result in changes in retinal morphology already
early in development that contribute to the overall dysfunction in
retinal transmission as suggested from recent studies in Cav1.4 deﬁ-
cient mice [42,47]. Potential pharmaco-therapeutic interventions
might therefore have to be applied early in development. Gene ther-
apeutic approaches focus on recombinant viral vectors as promising
vehicles for therapeutic gene delivery to the retina (for review see
e.g. [48,49]). Gene therapy may be applicable in patients carrying
the R1827Xmutation. This conjecture is supported by our rescue ex-
periment. It is also conceivable that patients with a mutation pheno-
typically related to the L860P may beneﬁt from gene therapy. It is,
however, worthwhile to consider an alternative approach, i.e.,
pharmacochaperoning by using ligands that stabilize folding intermedi-
ates in the endoplasmic reticulum and thus prevent ER-associated deg-
radation. Understanding the folding trajectory of Cav1.4 will be helpful
in the search for ligands that act as pharmacochaperones. In the mean-
time, it is worth noting that valproic acid has been suggested to act as
pharmacological chaperone for unfolded proteins and is being explored
in an ongoing clinical trial in patientswith autosomal dominant retinitis
pigmentosa (http://clinicaltrials.gov/ct2/show/study/NCT01233609).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2014.04.023.Acknowledgements
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